Loading…
Loading…
EQUITY / NYSE · XASE
VolitionRx Limited
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.2379 USD · 2.5431%
Observed: Oct 6, 2026, 2:45 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/05/2026 · 0.232 USD · Volume 716,939
63 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 398,657 USD | 406,688 USD | -1.97% |
| Operating profit | -4,155,983 USD | -6,297,807 USD | — |
| Net income | -7,326,047 USD | -6,284,078 USD | — |
| Cash and cash equivalents | 2,800,000 USD | — | — |
| Total liabilities | 41,840,346 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 2,800,000 USD | — | — | — | 1,117,028 USD | 200,000 USD | — | — |
| Net incomeIncome statement | -7,326,047 USD | -13,990,821 USD | -6,703,557 USD | — | -23,357,027 USD | -5,378,358 USD | -17,086,195 USD | -6,284,078 USD |
| Operating profitIncome statement | -4,155,983 USD | -9,527,671 USD | — | — | -21,738,571 USD | -5,100,990 USD | -16,920,187 USD | -6,297,807 USD |
| RevenueIncome statement | 398,657 USD | 1,383,733 USD | — | — | 1,727,384 USD | 627,277 USD | 1,280,350 USD | 406,688 USD |
| Total assetsBalance sheet | 8,300,986 USD | — | — | 6,901,227 USD | 6,901,227 USD | 6,448,885 USD | — | — |
| Total equityBalance sheet | -32,164,943 USD | — | -33,359,929 USD | -34,246,393 USD | -34,246,393 USD | -34,635,153 USD | — | -33,098,322 USD |
| Total liabilitiesBalance sheet | 41,840,346 USD | — | — | 42,494,038 USD | 42,494,038 USD | 42,398,447 USD | — | — |
| Capital expendituresCash flow statement | — | 11,002 USD | — | — | 89,558 USD | — | 78,591 USD | — |
| Financing cash flowCash flow statement | — | 12,595,212 USD | — | — | 17,092,858 USD | — | 10,937,053 USD | — |
| Investing cash flowCash flow statement | — | -11,002 USD | — | — | -89,558 USD | — | -78,591 USD | — |
| Operating cash flowCash flow statement | — | -10,439,781 USD | — | — | -19,683,334 USD | — | -14,191,467 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/31/2026 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 11/13/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.